Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco A Mauri

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Oncoimmunology|October 21, 2016
Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapyDavid J Pinato, Robert J Shiner, Solomon D T White, et al.
Oncology Reports|September 17, 2011
Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinomaBarbara Vizio, Francesco A Mauri, Adriana Prati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2015
Membrane Type 1 Matrix Metalloproteinase Regulates Monocyte Migration and Collagen Destruction in TuberculosisTarangini Sathyamoorthy, Liku B Tezera, Naomi F Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2025
Correction: Targeting the Phosphoinositide 3-Kinase p110-α Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung CancerAnna Wojtalla, Barbara Fischer, Nataliya Kotelevets, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2012
Targeting the phosphoinositide 3-kinase p110-α isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancerAnna Wojtalla, Barbara Fischer, Nataliya Kotelevets, et al.
Oncogene|March 12, 2020
Immune-based therapies for hepatocellular carcinomaDavid J Pinato, Nadia Guerra, Petros Fessas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2020
Qualification of tumour mutational burden by targeted next-generation sequencing as a biomarker in hepatocellular carcinomaChing Ngar Wong, Petros Fessas, Kathy Dominy, et al.
Plos One|February 23, 2010
Endothelial cell processing and alternatively spliced transcripts of factor VIII: potential implications for coagulation cascades and pulmonary hypertensionClaire L Shovlin, Gillian Angus, Richard A Manning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001Marin Marinov, Algirdas Ziogas, Olivier E Pardo, et al.
Neuroendocrinology|February 26, 2020
Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine TumoursDavid J Pinato, Anu Vallipuram, Joanne S Evans, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Oncoimmunology|October 21, 2016
Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapyDavid J Pinato, Robert J Shiner, Solomon D T White, et al.
Oncology Reports|September 17, 2011
Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinomaBarbara Vizio, Francesco A Mauri, Adriana Prati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2015
Membrane Type 1 Matrix Metalloproteinase Regulates Monocyte Migration and Collagen Destruction in TuberculosisTarangini Sathyamoorthy, Liku B Tezera, Naomi F Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2025
Correction: Targeting the Phosphoinositide 3-Kinase p110-α Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung CancerAnna Wojtalla, Barbara Fischer, Nataliya Kotelevets, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2012
Targeting the phosphoinositide 3-kinase p110-α isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancerAnna Wojtalla, Barbara Fischer, Nataliya Kotelevets, et al.
Oncogene|March 12, 2020
Immune-based therapies for hepatocellular carcinomaDavid J Pinato, Nadia Guerra, Petros Fessas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2020
Qualification of tumour mutational burden by targeted next-generation sequencing as a biomarker in hepatocellular carcinomaChing Ngar Wong, Petros Fessas, Kathy Dominy, et al.
Plos One|February 23, 2010
Endothelial cell processing and alternatively spliced transcripts of factor VIII: potential implications for coagulation cascades and pulmonary hypertensionClaire L Shovlin, Gillian Angus, Richard A Manning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001Marin Marinov, Algirdas Ziogas, Olivier E Pardo, et al.
Neuroendocrinology|February 26, 2020
Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine TumoursDavid J Pinato, Anu Vallipuram, Joanne S Evans, et al.
Pageof 3